Organisations who operate in the safety critical domains such as the medical device, avaition, and automotive domains must ensure their software is safe and provide objective evidence to this effect. One way of achieving this is by adhering to domain specific regulations and guidelines which specify a comprehensive implementation of traceability. However there is a gap between regulatory traceability requirements and what is implemented in practice. This lack of compliance means that organisations find it difficult to assess the safety of their software and thus ensure its safety. One reason for non-compliance with regards to traceability is a lack of guidance on what traceability to implement or how to implement it. In this paper we present the development and validation of a roadmap for the implementation of traceability in the medical device domain. The roadmap will provide medical device organisations with a pathway for effective traceability implementation.
Introduction
Developing software in the safety critical domain is a difficult task as manufacturers must comply with numerous regulations and guidelines. Additionally, it is incumbent on the manufacturers of such software to prove that their software is safe. This involves submission of a safety case which is a reasoned argument supported with objective evidence proving that the software is safe for its intended use [1] . Establishing effective software development processes that are based on recognised engineering principles appropriate for safety critical systems will greatly contribute towards the safety of the software. At the heart of such processes they must incorporate traceability. Traceability is the ability to establish links (or traces) between source artefacts and target artefacts [2] . Tracing, which is the process of developing traces, is an important technique that can help to ensure that the right system is being designed and implemented. It is important to implement "just the right amount" of traceability in "just the right way" so that the risk-to-reward ratio benefits a project's circumstances. Otherwise, you may find that: G. Regan et al.
1.
A project suffers from excessive overhead without commensurate quality improvement.
2. The project fails to deliver the requisite quality Neither of these outcomes is desirable therefore it is beneficial to define and implement the right traceability strategy from the beginning. In the medical device domain, the "right amount" of traceability is determined by the medical device standards and guidelines. These standards require traceability between each phase of the Software Development Lifecycle (SDLC), Risk Management and Change Management processes, e.g. traceability between software requirements and software architectural design. This standards' traceability requirements ensure verification of inputs to outputs. Additionally, the "right way" is influenced by traceability best practices.
However despite the regulatory requirements for traceability and the many benefits it has to offer, most existing software systems lack explicit traceability links between artefacts [3] and required phases. This leads to difficulties in verifying and validating the software. Numerous reasons have been identified for reluctance in implementing traceability, including a lack of guidance in terms of what traces to implement and how to implement them. As a result practitioners are ill informed as to how best to accomplish this task [4, 5] . To assist medical device organisations in addressing the lack of guidance on how to implement effective traceability, this paper presents the development and validation of a traceability roadmap.
While there is no standard definition of a roadmap, many definitions do exist, for example a roadmap is 'the view of a group of stakeholders as to how to get where they want to go to achieve their desired objective '[6] , or a roadmap is 'a series of milestones, comprised of goals, that will guide an organisation, through the use of specific activities, towards compliance with regulatory standards' [7] . In effect a roadmap is a plan that allows organisations put solutions in place in order to achieve specific goals.
The remainder of this paper is structured as follows: Section 2 outlines various types of roadmaps and roadmap development methodologies while Section 3 outlines the development methodology used to develop the roadmap presented in this paper.
Section 4 details the structure of the developed roadmap while Section 5 presents the findings of an expert evaluation of the roadmap and a discussion of those findings, while Section 6 concludes the paper. 
